Pancreatic cancer cells invasiveness is mainly affected by interleukin-1β not by transforming growth factor-β1

International Journal of Biological Markers

Volumn 20, Issue 4, 2005, Pages 235-241

  Greco, E ^a   Basso, D ^a   Fogar, P ^b   Mazza, S ^a   Navaglia, F ^a   Zambon, C F ^b   Falda, A ^a   Pedrazzoli, S ^b   Ancona, E ^c   Plebani, Mario ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Extracellular matrix; Interleukin 1 ; Matrigel; Metastasis; Pancreatic cancer; Transforming growth factor 1

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; INTERLEUKIN 1BETA; LAMININ; MATRIGEL; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; CORRELATION FUNCTION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; METASTASIS POTENTIAL; PANCREAS CANCER; STATISTICAL ANALYSIS;

EID: 30844470670     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080502000406     Document Type: Article

References (36)

1. Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 2000; 78: 31-101.
2. Keleg S, Büchler P, Ludwig R, Büchler MW, Friess H. Invasion and metastasis in pancreatic cancer. Mol Cancer 2003; 2: 14-20.
3. Dejana E, Bertocchi F, Bortolami MC, et al. Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Invest 1988; 82: 1466-70.
4. Albo D, Berger DH, Tuszynski GP. The effect of throm-bospondin-1 and TGF-β1 on pancreatic cancer cell invasion. J Surg Res 1998; 76: 86-90.
5. Stefani AL, Basso D, Panozzo MP, et al. Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. Pancreas 1999; 19: 362-9.
6. Sawai H, Takeyama H, Yamamoto M, et al. Enhancement of integrins by interleukin-1α, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells. J Surg Oncol 2003; 82: 51-6.
7. Müerköster S, Wegehenkel K, Arlt A, et al. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1 beta. Cancer Res 2004; 64: 1331-7.
8. Baldwin RL, Korc M. Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. Growth Factors 1993; 8: 23-34.
9. Friess H, Yamanaka Y, Büchler MW, et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993; 105: 1846-56.
10. Vidal-Vanaclocha F, Amèzaga C, Asumendi A, Kaplanski G, Dinarello CA. Interleukin-1 receptor blockade reduces the number and the size of murine B16 melanoma hepatic metastases. Cancer Res 1994; 4: 2667-72.
11. Derynck R, Akhurst RJ, Balmain A. TGF-β1 signaling in tumor suppression and cancer progression. Nature Genet 2001; 29: 117-29.
12. Ellenrieder V, Hendler SF, Ruhland C, Boeck W, Adler G, Gress TM. TGF-β1 induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int J Cancer 2001; 93: 204-11.
13. Teraoka H, Sawada T, Yamashiti Y, et al. TGF-β1 promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion. Int J Oncol 2001; 19: 709-15.
14. Wakefield LM, Roberts AB. TGF-β1 signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Develop 2002; 12: 22-9.
15. Voronov E, Shouval IDS, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003; 100: 2645-50.
16. Matsuo Y, Sawai H, Funahashi H, et al. Enhanced angio-genesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential. Pancreas 2004; 28: 344-52.
17. Pepper MS. Transforming growth factor-beta: vasculogenesis, angiogenesis and vessel wall integrity. Cytokine Growth Factor Rev 1997; 8: 21-43.
18. Massaguè J. How cells read TGF-β1 signals. Nature Rev Mol Cell Biol 2000; 1: 169-78.
19. Simeone DM, Zhang L, Graziano K, et al. Smad4 mediates activation of mitogen-activated protein kinase by TGF-β in pancreatic acinar cells. Am J Physiol Cell Physiol 2001; 281: C311-9.
20. Goggins M, Shekher M, Turnacioglu K, Yeo Q, Hruban RH, Kern SE. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 1998; 58: 5329-32.
21. Schwarte-Waldhoff I, Volpert OV, Bouck NP, et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA 2000; 97: 9624-9.
22. Jonson T, Albrechtsson E, Axelson J, et al. Altered expression of TGFB receptor and mitogenic effects of TGFB in pancreatic carcinomas. Int J Oncol 2001; 19: 71-81.
23. Liu F. SMAD/DPC4 and pancreatic cancer survival. Clin Cancer Res 2001; 7: 3853-6.
24. Maurice D, Pierreux CE, Howell M, Wilentz RE, Owen MJ, Hill CS. Loss of smad4 function in pancreatic tumors. J Biol Chem 2001; 276: 43175-81.
25. Jonson T, Heidenblad M, Håkansson P, et al. Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFBI. Genes Chromosomes Cancer 2003; 36: 340-52.
26. Brooks JW, Mizel SB. Interleukin-1 signal transduction. Eur Cytokine Net 1994; 5: 547-61.
27. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Net 1994; 5: 517-31.
28. Sawai H, Funahashi H, Yamamoto M, et al. Interleukin-1α enhances integrin a6β1 expression and metastatic capability of human pancreatic cancer. Oncology 2003; 65: 167-73.
29. Zambon C-F, Basso D, Navaglia F, et al. Helicobacter pylori virulence genes and host IL-1 RN and IL-1β genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine 2002; 18: 242-51.
30. Barber MID, Powell JJ, Lynch SF, Fearon KC, Ross JA. A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 2000; 83: 1443-7.
31. Hwang I-R, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-803.
32. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-45.
33. Fogar P, Greco E, Basso D, et al. Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model. Eur J Surg Oncol 2003; 29: 721-30.
34. Sipos B, Moser S, Kalthoff H, Torok V, Lohr M, Kloppel G. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 2003; 442: 444-52.
35. Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW. Rap1 reverses transcriptional repression of TGF-P type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1. J Cell Physiol 2002; 194: 88-99.
36. Basso D, Plebani M, Fogar P, et al. Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes. Int J Clin Lab Res 1995; 25: 40-3.